跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet bottle
Approved
STANDARD
SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet bottle
Gilead Sciences Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
14b707a7ec851b6e
Company
Gilead Sciences Pty Ltd
Type
Standard
Approval Details
Approval Id
14b707a7ec851b6e
Product Name
SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet bottle
Artg Id
468505
Artg Name
SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet bottle
Sponsor
Gilead Sciences Pty Ltd
Company Detail Path
/organization/gilead-sciences-pty-limited
Artg Date
2025-07-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a8b6518a66e6db043bece8503b8b4924.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1481f4e94c6db4a9e4514429e19d932f.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
14b707a7ec851b6e
Type
Standard
Back to TGA Approvals
SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet bottle - TGA Drug Approval Details